Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Daily consistency is what matters most
Beneficiaries prescribed an eligible GLP-1 drug for a covered use under standard Medicare Part D, such as Wegovy to reduce MACE risk in adults with cardiovascular disease and obesity or overweight, would not qualify for coverage under the Medicare GLP-1 Bridge and have to seek coverage through their Part D plan's existing formulary exception processes
This is why lifestyle support alongside medication is the gold standard approach to GLP-1 therapy
Protein, essential fatty acids, vitamins, and minerals all become harder to consume in adequate amounts
Its time to work with it, not against it.
US$ 26.55
US$ 22.45
US$ 20.74
US$ 22.83
US$ 25.30
